FirmaIQ
Org.nr 895 811 572 2022 → 2023 Year-over-year analysis

ABDALY SPESIALIST ALLMENNMEDISIN AS: årsregnskap 2023 vs 2022

Grew 13% on revenue, weaker earnings, cash halved-plus

approved 2024-10-11; registry 2024-10-14; journal 2024 752553

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2023 with 2022 for ABDALY SPESIALIST ALLMENNMEDISIN AS. Revenue 8.01m NOK → 9.08m NOK (+13.4%). Net result +7.11m NOK → +3.85m NOK. Equity 19.44m NOK → 23.30m NOK.

On the constructive side: revenue rose; operating result improved; equity strengthened. Pressures included: net result weakened; cash fell.

Also worth watching: payroll increased. All figures are taken from the published annual accounts for ABDALY SPESIALIST ALLMENNMEDISIN AS.

At a glance

Scorecard

Revenue
8.01m NOK 9.08m NOK
+13.4%
Operating result
+4.83m NOK +5.58m NOK
+15.3%
Net result
+7.11m NOK +3.85m NOK
-45.8%
Equity
19.44m NOK 23.30m NOK
+19.8%
Cash
838.3k NOK 159.2k NOK
-81.0%
Total assets
21.75m NOK 25.08m NOK
+15.3%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 8.01m NOK to 9.08m NOK (+13.4% YoY). Calculated

  • ↑

    Operating result improved

    Operating result +4.83m NOK → +5.58m NOK (op. margin 60.4% → 61.4%). Calculated

  • ↑

    Equity strengthened

    Book equity 19.44m NOK → 23.30m NOK (equity ratio 89.4% → 92.9%). Calculated

What deteriorated

  • ↓

    Net result weakened

    Net result +7.11m NOK → +3.85m NOK (net margin 88.8% → 42.5%). Calculated

  • ↓

    Cash fell

    Bank deposits 838.3k NOK → 159.2k NOK (-81.0% YoY). Calculated

Things to notice

  • ·

    Payroll increased

    Salary cost 1.73m NOK → 2.04m NOK (22% → 22% of revenue). Calculated